Dr. Ashutosh Kaushik

D.D.S | Dentist



  
  Rush 1653 W. Congress Parkaway, Chicago
  Illinois, 60612

  678-451-6607    Maps & Directions
Dr. Ashutosh Kaushik is a Chicago, Illinois based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is Rush 1653 W. Congress Parkaway, Chicago. Patients can reach him at 678-451-6607.
Dr. Ashutosh Kaushik is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Ashutosh Kaushik speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Ashutosh Kaushik
Specialization: Dentist
Gender:Male
Credentials: D.D.S
Accepts Medicare Assignment:May Accept
Practice Address:Rush 1653 W. Congress Parkaway, Chicago,
Illinois, 60612
Phone:678-451-6607
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6103046578
Enrollment ID: I20141007000808
NPI Number: 1346553716
NPI Enumeration Date: 14 Jul, 2010
NPI Last Update On: 14 Jul, 2010

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Rush 1653 W. Congress Parkaway,
Chicago, Illinois
Zip: 60612
Phone Number: 678-451-6607
Patients can reach Dr. Ashutosh Kaushik at Rush 1653 W. Congress Parkaway, Chicago, Illinois or can call to book an appointment on 678-451-6607. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: